Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × tisagenlecleucel × Lymphoid × Clear all

Status

Completed 12 Recruiting 5 Active not recruiting 5 Terminated 2 Withdrawn 1 Suspended 1 Not yet recruiting 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

venetoclax 1 tisagenlecleucel 1 tipifarnib 1 selinexor 1 ceritinib 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 Proton Pump Inhibitors 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03601442 2025-12-05

CTL019 Out of Specification MAP for ALL or DLBCL Patients

Novartis

LymphoidOther hematologic neoplasm

Recurrence, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡